论文部分内容阅读
在哮喘治疗中,β2受体激动剂和激素的联合应用一直有异议,近年来,由于长效β2受体激动剂的应用使传统的观点受到了挑战;本文就目前研究的相关动态予以综述。
The combination of beta 2 agonists and hormones has long been objectionable in the treatment of asthma. In recent years traditional wisdom has been challenged by the use of long-acting beta 2 agonists; the current state of the art is reviewed in this article.